long term side effects of glp-1 receptor agonists Your guide to Gastrointestinal Adverse Effects of GLP-1

When you lose weight, you run the risk of bone loss, said Apovian, who was not involved in the study

Expected Cholesterol Changes During GLP-1 Treatment Clinical data shows that patients on GLP-1 therapy see average reductions in LDL cholesterol of 10 to 15 percent within the first three months of consistent use

but widespread use of these drugs is still relatively recent

Some users have claimed to experience side effects such as nausea, vomiting, and digestive issues

In the case of alogliptin, the exact exposure time was not reported in the manuscript

The information in this article is for educational purposes only and should not be considered medical advice